middle.news
EMVision Secures $3M Grant Amid Rising Losses and R&D Expansion
9:30am on Monday 23rd of February, 2026 AEDT
•
Healthcare
Read Story
EMVision Secures $3M Grant Amid Rising Losses and R&D Expansion
9:30am on Monday 23rd of February, 2026 AEDT
Key Points
Half-year loss increased 11% to $3.97 million
Income rose 6% to $4.05 million, including grants and R&D tax incentives
Secured $3 million non-dilutive government grant for regional stroke study
Operating expenses up due to pilot manufacturing and expanded clinical trials
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
EMVISION MEDICAL DEVICES (ASX:EMV)
OPEN ARTICLE